Atlanta Braves Holdings, Inc. (BATRA) officer Michael P. Plant reported a proposed sale of 15,193 Series C Common Stock shares, with an aggregate market value of $790,036.00 and an approximate sale date of November 11, 2026. Charles Schwab Corp. is listed as the broker. The remarks name the account as “THE Mike Plant 2022 Grantor Retained Annuity TR” and identify Michael P. Plant as trustee. The notice also lists prior sales: 57,395 shares on November 9, 2026, for gross proceeds of $2,943,331.15; 57,000 shares on November 10, 2026, for $2,976,180.56; and 57,000 shares on November 11, 2026, for $2,951,850.30.
Atlanta Braves Holdings, Inc. (BATRA) officer Michael P. Plant is identified for a proposed sale of 171,395 shares of Series C Common Stock, with an aggregate market value of $8,801,133.25 and an approximate sale date of November 9, 2026.
The shares are listed as acquired through exercise of stock options, with cash payment. The stated Rule 10b5-1 plan adoption date is August 7, 2026. The company had 53,203,078 shares of Series C Common Stock outstanding.
Atlanta Braves Holdings, Inc. (BATRA) reported third-quarter revenue of $324.6 million, compared with $311.5 million a year earlier, while net earnings attributable to stockholders were $9.8 million versus $30.0 million. For the nine months ended September 30, 2026, revenue was $701.8 million and net loss attributable to stockholders was $42.9 million, versus earnings of $18.1 million a year earlier.
Nine-month Adjusted OIBDA was $34.8 million, compared with $104.3 million, and operating income was a loss of $51.1 million versus income of $36.3 million. Baseball operating costs increased $83.5 million, including increases in major-league player salaries and BravesVision production costs; media-related revenue declined $13.1 million. Mixed-Use Development revenue was $84.0 million, compared with $70.9 million.
Cash and cash equivalents were $121.5 million as of September 30, 2026; operating activities used $65.5 million in cash during the nine-month period, and total debt was $813.3 million. The current MLB collective bargaining agreement is scheduled to expire December 1, 2026; Atlanta Braves Holdings says it cannot predict whether a successor agreement will be reached before then.
Atlanta Braves Holdings, Inc. (BATRA) reported third-quarter 2026 revenue of $324.6 million, up 4%, while Adjusted OIBDA was $40.6 million, down 40%. Operating income fell 78% to $8.7 million; net earnings attributable to stockholders were $9.8 million versus $30.0 million a year earlier.
Baseball revenue rose 4% to $295.5 million, with baseball event revenue up 7% and retail and licensing up 25%; media-related revenue fell 4%. Mixed-Use Development revenue rose 7% to $29.1 million. Management attributed event-revenue growth to ticket rates, attendance and postseason games; higher operating and selling, general and administrative costs primarily drove lower operating income and Adjusted OIBDA. The quarter had 44 home games, including two postseason games, versus 41 a year earlier.
For the first nine months of 2026, revenue was $701.8 million, up 5%, and Adjusted OIBDA was $34.8 million, down 67%; operating income was a $51.1 million loss versus $36.3 million income. At September 30, 2026, cash was $121.5 million and total debt (GAAP) was $813.3 million. Operating cash flow for the nine months was a $65.5 million outflow.
Atlanta Braves Holdings, Inc. EVP, Business Derek Gordon Schiller exercised options to acquire 175,395 Series C Common Stock shares at an exercise price of $27.18 per share on September 30, 2026, then sold 175,395 shares at a weighted average price of $53.20 per share. The sale prices ranged from $52.41 to $54.10 per share. The sale was made under a Rule 10b5-1 sales plan adopted June 30, 2026.
Atlanta Braves Holdings, Inc. executive Gregory John Heller, EVP, CLO & Secretary, exercised options covering 80,263 Series C Common Stock shares at an exercise price of $27.18 per share on September 29, 2026, then sold 80,263 shares at a weighted-average price of $53.89 per share. The sale was effected under a Rule 10b5-1 sales plan adopted on June 30, 2026.
Atlanta Braves Holdings, Inc. officer Derek Gordon Schiller reported a proposed sale of 175,395 shares of Series C Common Stock, with an aggregate market value of $9,460,806.30 and an approximate sale date of September 30, 2026. The shares are listed as acquired from the issuer through an exercise of stock options, with cash payment. UBS Financial Services, Inc. is named as broker, and Nasdaq is identified as the exchange.
Atlanta Braves Holdings, Inc. (BATRA) officer Gregory John Heller reported a proposed sale of 80,263 Series C common shares, with an approximate sale date of September 29, 2026. The securities information lists an aggregate market value of $4,344,636.19 and names UBS Financial Services Inc. as broker. The shares are listed as acquired through an exercise of a stock option from the issuer.
Atlanta Braves Holdings, Inc. (BATRA) has more than 30.16% of its Series A common stock reported as beneficially owned by a group of entities associated with Mario Gabelli, according to an amended Schedule 13D. The group reports beneficial ownership of 3,112,256 shares out of 10,318,187 shares outstanding as of June 30, 2026.
The largest holder in the group is GAMCO Asset Management Inc. with 2,008,722 shares (about 19.47% of the class), followed by Gabelli Funds LLC with 897,332 shares (about 8.70%). The Reporting Persons state that they are using the long-form Schedule 13D so that ongoing communications with Atlanta Braves Holdings’ management remain consistent with Exchange Act reporting obligations. Each reporting entity generally has sole voting and dispositive power over its reported shares, subject to specified exceptions and internal fund proxy-voting procedures.
Atlanta Braves Holdings, Inc. (BATRA/BATRK) reported insider transactions by Jill L. Robinson, EVP, CFO & Treasurer. On August 19, 2026, she exercised options for 30,263 shares of Series C Common Stock at an exercise price of $27.18 per share and then sold 30,263 shares at a weighted average price of $52.84 per share, under a Rule 10b5-1 sales plan adopted on May 18, 2026.